Invasive Lobular Carcinoma Survivor Story
This breast cancer diagnosis at a glance
- Subtype
- Invasive Lobular Carcinoma
- Biomarkers
- Hormone-dependent; grade II
- Sex
- Female
- Treatment
- complementary therapy and surveillance
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- July 2018 diagnosis of hormone-dependent grade II bifocal invasive lobular carcinoma, with 2 nodules measuring 18 mm and 15 mm
- patient declined proposed mastectomy, chemotherapy, radiation, and hormone therapy
- ketogenic diet plus metabolic treatment, with follow-up ultrasound and blood tests every 3 months
- after 9 months, cancer had decreased by 10 mm
- 12 September 2019 ultrasound and mammogram showed the nodules were no longer present
- 18 September oncology visit confirmed nodule disappearance.
What happened, in summary
A 59-year-old woman was diagnosed in July 2018 with hormone-dependent, grade II bifocal invasive lobular breast cancer. The cancer involved 2 nodules, one measuring 18 mm and the other 15 mm. After several oncology visits, she decided not to follow the proposed conventional protocol, which she described as breast removal, chemotherapy, radiation, and hormone therapy. Instead, she chose to keep her breast and follow a ketogenic diet plus metabolic treatment. She cut out sugar, pasta, bread, rice, starches, dairy products, gluten, and meat, and continued regular monitoring with ultrasound and blood tests every 3 months. After 9 months, she reported that the cancer had decreased by 10 mm and that her blood tests were very good. On September 12, 2019, 12 months after diagnosis, ultrasound and mammography showed that the nodules were no longer visible. On September 18, her oncologist concluded that the nodules had disappeared. Her experience highlights a deeply personal treatment decision, close imaging follow-up, and the emotional pull between conventional recommendations and a path she felt able to follow after diagnosis. It also shows why grade and stage should not be confused: her text describes grade II lobular cancer, while no formal stage is given.
Where this story comes from
This is a lay summary of an account first published by Cancer et Métabolisme. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer